https://pharmadog.xyz/news/352194 pharmadog en 2026-09-01T18:32:08.000Z ARPA-H grants up to $125M to accelerate on-demand custom RNA therapy manufacturing https://pharmadog.xyz/news/352195 pharmadog en 2026-09-01T18:16:50.000Z Trump announces voluntary pricing agreements with nine new drug makers https://pharmadog.xyz/news/352099 pharmadog en 2026-09-01T18:09:57.000Z House passes stopgap bill to block White House plan for political control of federal research grants https://pharmadog.xyz/news/352100 pharmadog en 2026-09-01T17:28:37.000Z Trial over Lindsay Clancy’s case threatens progress in postpartum psychiatry https://pharmadog.xyz/news/352035 pharmadog en 2026-09-01T17:12:58.000Z Arsenal Biosciences trims most of its workforce as it shifts focus to in vivo CAR T therapy https://pharmadog.xyz/news/351863 pharmadog en 2026-09-01T16:14:00.000Z Mid-size biotechs join White House Medicaid pricing program, gain tariff relief https://pharmadog.xyz/news/351864 pharmadog en 2026-09-01T15:58:00.000Z Novartis reports Phase 3 success for MS pill remibrutinib, beats Aubagio and shows no liver safety issues https://pharmadog.xyz/news/351803 pharmadog en 2026-09-01T15:28:05.000Z Roche partners with China's Simcere Zaiming on $1.5 billion T-cell engager for B-cell diseases https://pharmadog.xyz/news/351865 pharmadog en 2026-09-01T15:28:00.000Z Alumis' TYK2 inhibitor flunks mid-stage lupus trial, shares drop 55% https://pharmadog.xyz/news/351583 pharmadog en 2026-09-01T15:01:06.000Z Eli Lilly's 2026 acquisitions boost over 50 biotech venture investors https://pharmadog.xyz/news/351823 pharmadog en 2026-09-01T14:51:22.000Z STAT+: 5 burning questions on Trump’s latest deals with drugmakers https://pharmadog.xyz/news/351584 pharmadog en 2026-09-01T14:40:34.000Z GSK to begin Phase 3 trial of mRNA seasonal flu vaccine after strong Phase 2 results https://pharmadog.xyz/news/351585 pharmadog en 2026-09-01T14:40:27.000Z Roche partners with Simcere Zaiming on trispecific T cell engager, $75M upfront https://pharmadog.xyz/news/351586 pharmadog en 2026-09-01T14:24:39.000Z Alumis' TYK2 drug fails in lupus trial; CEO sees 'clear path forward' https://pharmadog.xyz/news/351656 pharmadog en 2026-09-01T14:09:09.000Z GSK to launch Phase 3 trial for mRNA-based flu vaccine amid resurgence for the modality https://pharmadog.xyz/news/134233 pharmadog en 2026-09-01T14:08:00.000Z CLINUVEL to cut up to 20% of staff and move headquarters to New York https://pharmadog.xyz/news/351479 pharmadog en 2026-09-01T13:34:13.000Z Novartis reports positive multiple sclerosis results with its BTK inhibitor https://pharmadog.xyz/news/351480 pharmadog en 2026-09-01T13:21:06.000Z Novartis and Bristol Myers Squibb pause cell therapy trials; $480K cancer drug price now routine, new pricing deals announced https://pharmadog.xyz/news/351351 pharmadog en 2026-09-01T13:10:20.000Z FDA clears Stryker’s surgical cockpit that integrates Apple Vision Pro VR headset https://pharmadog.xyz/news/351352 pharmadog en 2026-09-01T13:08:31.000Z Study finds Paxlovid ineffective for treating long Covid https://pharmadog.xyz/news/351307 pharmadog en 2026-09-01T13:00:43.000Z K Health plans IPO by 2029 after recent funding round https://pharmadog.xyz/news/351331 pharmadog en 2026-09-01T12:20:57.000Z Arsenal Biosciences cuts 99 jobs as it pivots to in vivo CAR-T therapy https://pharmadog.xyz/news/351203 pharmadog en 2026-09-01T12:03:04.000Z House set to vote on stopgap bill that could block White House plan to politicize NIH grants https://pharmadog.xyz/news/351183 pharmadog en 2026-09-01T12:02:14.000Z Nine midsize biopharma firms join Trump MFN drug pricing program, covering 89% of branded market https://pharmadog.xyz/news/351184 pharmadog en 2026-09-01T11:54:53.000Z Novartis pauses CAR T studies due to 3 deaths; BMS follows suit after safety events https://pharmadog.xyz/news/351139 pharmadog en 2026-09-01T11:30:44.000Z Novartis' Rhapsido safer than rivals, Phase 3 multiple sclerosis data suggest https://pharmadog.xyz/news/351558 pharmadog en 2026-09-01T10:01:00.000Z Roche inks $1.53B deal for Simcere’s B-cell-targeting antibody https://pharmadog.xyz/news/351559 pharmadog en 2026-09-01T09:51:00.000Z ArsenalBio sheds most of staff in pivot to in vivo CAR-T https://pharmadog.xyz/news/351391 pharmadog en 2026-09-01T09:28:00.000Z Alumis crushed by midstage lupus flop but plots path to phase 3 for TYK2 inhibitor https://pharmadog.xyz/news/351392 pharmadog en 2026-09-01T09:02:00.000Z Novocure hit by cyberattack exposing patient data https://pharmadog.xyz/news/350691 pharmadog en 2026-09-01T08:30:00.000Z NIH proposes cap on individual research grants, drawing mixed reactions https://pharmadog.xyz/news/350693 pharmadog en 2026-09-01T08:30:00.000Z Dietitian Shortage Threatens Trump Administration's Nutrition Initiatives https://pharmadog.xyz/news/350692 pharmadog en 2026-09-01T08:30:00.000Z Opinion: Trump administration’s paperwork surge hampers science and health care https://pharmadog.xyz/news/350730 pharmadog en 2026-09-01T05:43:00.000Z GSK's mRNA flu vaccine shows stronger immune response than standard shots in phase 2, prompting phase 3 launch https://pharmadog.xyz/news/351499 pharmadog en 2026-09-01T04:00:00.000Z Breathing Circuit Recall: Medline Removes Neonatal and Infant Heated Wire Breathing Circuits https://pharmadog.xyz/news/351390 pharmadog en 2026-09-01T03:18:00.000Z Medtronic recalls reflux monitoring device as 184 serious injuries linked to capsule https://pharmadog.xyz/news/351282 pharmadog en 2026-09-01T02:47:00.000Z Boston Scientific halts sales of angiographic catheters amid 2 serious injuries https://pharmadog.xyz/news/349435 pharmadog en 2026-09-01T00:55:30.000Z ARCH Venture Partners aims to raise $3 billion for its 14th biotech fund https://pharmadog.xyz/news/349159 pharmadog en 2026-09-01T00:01:19.000Z Novartis halts CD19 CAR-T trial after three deaths, Bristol Myers also pauses similar program https://pharmadog.xyz/news/348987 pharmadog en 2026-08-31T21:38:00.000Z Novartis and Bristol Myers pause autoimmune CAR-T trials after safety concerns https://pharmadog.xyz/news/348563 pharmadog en 2026-08-31T20:00:00.000Z New American Headache Society guidelines highlight expanded migraine prevention options https://pharmadog.xyz/news/348499 pharmadog en 2026-08-31T19:56:17.000Z Trump announces nine voluntary drug pricing agreements with mid-size biotech firms https://pharmadog.xyz/news/348564 pharmadog en 2026-08-31T19:48:44.000Z Trump announces nine new drug pricing agreements to align U.S. prices with peer nations https://pharmadog.xyz/news/348613 pharmadog en 2026-08-31T17:00:00.000Z Crystal Temptations Issues Allergy Alert on Undeclared Milk in Chocolatey Eyeballs https://pharmadog.xyz/news/348337 pharmadog en 2026-08-31T16:44:00.000Z Kofinas Olive Oil voluntarily recalls garlic-infused extra virgin olive oil over unapproved essential oil https://pharmadog.xyz/news/349026 pharmadog en 2026-08-31T16:20:00.000Z Novartis and Bristol Myers pause multiple autoimmune CAR-T trials after serious immune adverse events https://pharmadog.xyz/news/348051 pharmadog en 2026-08-31T16:13:00.000Z FDA clears Takeda and Protagonist's rusfertide (Mimrylo) for polycythemia vera, opening potential $2 billion market https://pharmadog.xyz/news/348011 pharmadog en 2026-08-31T15:56:53.000Z Amgen faces FTC-backed lawsuit over patent-application purchase amid insurer dispute https://pharmadog.xyz/news/347947 pharmadog en 2026-08-31T15:44:09.000Z Industry insiders invited to take Q3 BioPharma Sentiment Survey https://pharmadog.xyz/news/348012 pharmadog en 2026-08-31T15:27:30.000Z GLP-1 drugs push employers to rethink worker health-care costs https://pharmadog.xyz/news/348052 pharmadog en 2026-08-31T15:23:00.000Z Eli Lilly to acquire Merida Biosciences in near-$2.9 billion deal to expand immune-disease pipeline https://pharmadog.xyz/news/347844 pharmadog en 2026-08-31T15:06:50.000Z Biomarin nabs big royalties in achondroplasia patent settlement with Ascendis https://pharmadog.xyz/news/347884 pharmadog en 2026-08-31T14:49:00.000Z Cytokinetics reports Phase 3 success for Myqorzo but shares tumble as investors weigh market impact https://pharmadog.xyz/news/352010 pharmadog en 2026-08-31T14:48:00.000Z ESC: Alnylam's next-gen silencer sees silver linings after fallout of AZ, Ionis trial in ATTR-CM https://pharmadog.xyz/news/347731 pharmadog en 2026-08-31T14:28:28.000Z Sanofi-backed Electra Therapeutics files for Nasdaq IPO to fund Phase 2/3 immunology program https://pharmadog.xyz/news/347563 pharmadog en 2026-08-31T13:47:00.000Z Eli Lilly to acquire Merida Biosciences for up to $2.875 billion, bolstering its immunology pipeline https://pharmadog.xyz/news/347607 pharmadog en 2026-08-31T13:10:30.000Z Arrowhead’s plozasiran shows favorable safety in severe hypertriglyceridemia late-stage trials https://pharmadog.xyz/news/347479 pharmadog en 2026-08-31T13:03:22.000Z Eli Lilly to acquire Merida Biosciences in up to $2.9 billion deal for precision antibody-degrading therapies https://pharmadog.xyz/news/347499 pharmadog en 2026-08-31T13:03:11.000Z FDA approves Takeda/Protagonist cancer drug Mimrylo as White House readies new drug pricing deals, BioNTech ends colon vaccine trial https://pharmadog.xyz/news/347500 pharmadog en 2026-08-31T12:48:19.000Z Pregnancy hormone explored as possible guide for cardiovascular drug development https://pharmadog.xyz/news/347501 pharmadog en 2026-08-31T12:25:18.000Z Highlights from the European Society of Cardiology meeting and updates on radiopharmaceutical research https://pharmadog.xyz/news/347331 pharmadog en 2026-08-31T11:39:50.000Z Takeda and Protagonist Therapeutics receive FDA approval for rusfertide (Mimrylo) to treat polycythemia vera https://pharmadog.xyz/news/347922 pharmadog en 2026-08-31T11:28:00.000Z Electra Therapeutics files for Nasdaq IPO to fund phase 2/3 immunology and cancer programs https://pharmadog.xyz/news/347795 pharmadog en 2026-08-31T10:47:00.000Z AstraZeneca's oral relaxin agonist shows positive phase 2b results in chronic heart failure https://pharmadog.xyz/news/346967 pharmadog en 2026-08-31T09:00:00.000Z Verily, NVIDIA and NIH launch first multimodal AI model combining EHR and genomics https://pharmadog.xyz/news/346949 pharmadog en 2026-08-31T08:30:00.000Z Radiopharmaceutical experts urge pharma to adopt bolder dosing despite safety concerns https://pharmadog.xyz/news/346948 pharmadog en 2026-08-31T08:30:00.000Z Personalized mRNA melanoma vaccine shows clinical success, reviving optimism for the platform https://pharmadog.xyz/news/346947 pharmadog en 2026-08-31T08:30:00.000Z Study reports up to 25% of sampled NFL players had CTE at death, sparking calls for league-wide action https://pharmadog.xyz/news/347538 pharmadog en 2026-08-31T08:04:00.000Z Eli Lilly to acquire Merida Biosciences for up to $2.88 billion, adding autoimmune antibody-degrading pipeline https://pharmadog.xyz/news/348642 pharmadog en 2026-08-31T07:44:00.000Z Natera partners with Angiex to evaluate Signatera blood test in AGX101 cancer trial https://pharmadog.xyz/news/346267 pharmadog en 2026-08-31T05:01:00.000Z BMS leverages Celgene merger to revive neuroscience pipeline amid delayed readouts https://pharmadog.xyz/news/346119 pharmadog en 2026-08-31T04:04:00.000Z US biotech edge erodes as China overtakes in trials and research, raising security concerns https://pharmadog.xyz/news/349956 pharmadog en 2026-08-31T00:00:00.000Z FDA clears Protagonist-Takeda therapy for rare blood cancer as Lilly moves to buy Merida for up to $2.88 billion https://pharmadog.xyz/news/349954 pharmadog en 2026-08-31T00:00:00.000Z Industry and patient groups urge FDA to revise master protocol guidance https://pharmadog.xyz/news/349953 pharmadog en 2026-08-31T00:00:00.000Z Experts urge FDA to boost transparency of complete response letters and refine master protocol guidance https://pharmadog.xyz/news/349955 pharmadog en 2026-08-31T00:00:00.000Z India streamlines regulations for outsourced medical device sterilization